A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer

Autor: Kothari, Rushabh, Doshi, Maulik, Chaithanya, P.K., CT, Satheesh, Kumar, Anil, Mallavarapu, Krishna Mohan, Nagarkar, Rajnish, Mahobia, Vijay, Bhatt, Niraj, Priyadarshini, K.L., Gogia, Ajay, Maksud, Tanveer, Prasad, Saurabh, Velavan, K., L․K․, Rajeev, SS, Prakash, Talreja, Vikas, Kalra, Kaushal, Nemade, Bhushan, Dastidar, Aloke Ghosh, Gupta, Tarachand, Patil, Tushar, Bondarde, Shailesh, Patel, Pinakin, Gupta, Sudeep, Biswas, Ghanashyam, Vaghela, Manan, Mahato, Pinaki, Parekh, Honey, Kalloli, Mahesh, Shetty, Rachan, Prakash, Gaurav, Goel, Anil, Mandal, Srikrishna, Choudhury, Tamohan, Jain, Minish, Goswami, Chanchal, H․M․, Yathish Kumar, Mukherjee, K․K․, Shrivastava, Rahul, Parmar, Deven

Publikováno v: In Clinical Breast Cancer October 2024 24(7):639-646

Complementary and Alternative Medicine Use and Its Impact on the Delayed Presentation and Advanced Stage of Breast Cancer in Newly Diagnosed Indian Women

Autor: Pawar, Amol, Diwan, Ashok, Mahobia, Vijay

Publikováno v: Indian Journal of Medical and Paediatric Oncology; 20240101, Issue: Preprints

Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial.

Autor: Prabhash K; Medical Oncology, Tata Memorial Hospital, Mumbai, India., Deshmukh C; Deenanath Mangeshkar Hospital & Research Center, Pune, India., Malhotra H; Medical Oncology, Sriram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, India., Sharma A; Medical Oncology, All India Institute of Medical Sciences, New Delhi, India., Jain M; KEM Hospital and Research Center, Pune, India., Dhamne N; Kolhapur Cancer Center, Kolhapur, India., Nagarakar R; HCG Manavata Cancer Center, Nashik, India., Ganesan P; Department of Oncology, Jawaharlal Institute of Postgraduate Medical Education, Puducherry, India., Mahobia VK; Government Medical College, Nagpur, India., Das CK; Department of Radiotherapy and Oncology, Regional Cancer Center, PGIMER, Chandigarh, India., Kumar R; Department of Radiation Oncology, Regional Cancer Center, Trivandrum, India., Shivanna PS; Mysore Medical College and Research Institute and K.R. Hospital, Mysore, India., Avaronnan MP; Malabar Cancer Center, Kannur, India., Chaithanya PK; MNJ Institute of Oncology and Regional Cancer Center, Hyderabad, India., Chaudhary V; Medical Oncology, RST Regional Cancer Hospital and Research Center, Nagpur, India., Singh K; Medical Oncology, RST Regional Cancer Hospital and Research Center, Nagpur, India., Aagre S; Ayush Hospital, Mumbai, India., Ravishankar B; Omega Hospital Chinna Gadhili, Visakhapatnam, India., Mehta D; Nirmal Hospital, Surat, India., Shilpa K; Department of Medical Oncology, Andhra Medical College/King George Hospital, Visakhapatnam, India., Maniar V; MOC Vile Parle, Mumbai, India., Chatterjee K; Health Point Hospital, Kolkata, India., Majumdar SD; Head of Department, Radiotherapy, All India Institute of Medical Sciences, Bhubaneshwar, India., Dana R; Head of Department, Radiotherapy, SMS Medical College and Hospital, Jaipur, India., Noronha V; Tata Memorial Hospital, Mumbai, India., Menon N; Medical Oncology, Tata Memorial Hospital, Mumbai, India., Sharma A; Medical Department, Alkem Laboratories Limited, Mumbai, India., Pawar R; Medical Department, Alkem Laboratories Limited, Mumbai, India., Shahavi V; Medical Department, Alkem Laboratories Limited, Mumbai, India., Yadav R; Medical Department, Alkem Laboratories Limited, Mumbai, India., Aiwale A; Medical Department, Alkem Laboratories Limited, Mumbai, India.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2024 Nov; Vol. 10, pp. e2400059. Date of Electronic Publication: 2024 Nov 14.